Menu

Department of Defence Tender by Dg Armed Forces Medical Service (GEM/2025/B/6147134)

Human Insulin Analogue Glargine Recombinant DNA origin 450 IU or 1 point 5 ml PFS Disposable Pen wi

Goods
Qty:4,330
EMD: ₹2,520
Department of Defence Tender by Dg Armed Forces Medical Service (GEM/2025/B/6147134)

Tender Timeline

Tender Issue
April 24, 2025 at 4:59 PM

Tender Title: Procurement of Medicines

Reference Number: GEM/2025/B/6147134

Issuing Authority/Department

The tender is issued by the Department of Defence under the Ministry of Defence.

Scope of Work and Objectives

This tender focuses on the procurement of Human Insulin Analogue Glargine (Recombinant DNA origin) with a specification of 450 IU or 1.5 ml PFS Disposable Pen. The delivery includes a total quantity of 4,330 units of this essential medication, as well as associated products like Insulin Glulisine Injection Cartridge (100 IU/ml) in a 3 ml format. The key objective is to ensure the provision of high-quality insulin products to meet the healthcare needs of the Armed Forces.

Eligibility Criteria

Bidders must be registered entities capable of supplying the required medical products. Highlighted below are the eligibility criteria necessary for participation:

  • Valid registration in accordance with applicable laws.
  • Proven experience in supplying pharmaceutical products, particularly insulin and other diabetes management solutions.
  • Compliance with regulations set forth by health authorities.

Technical Requirements

Bidders must meet specific technical requirements which include:

  • Products must comply with standards set forth by relevant health authorities.
  • Documentation certifying the quality and authenticity of insulin and related products must be provided.
  • Items supplied must ensure safety and efficacy in treatment protocols.

Financial Requirements

Bidders are required to submit financial documents demonstrating their capacity to fulfill the order while adhering to set pricing structures consistent with market standards. Submission of previous sales records of similar goods may be helpful during evaluation.

Document Submission Details

All bids must be submitted electronically through the specified portal, ensuring that all required documentation is complete. Specific instructions regarding the format and documentation guidelines will be provided within the submission platform.

Special Provisions

  • Preference may be given to Micro, Small, and Medium Enterprises (MSEs) and startups catering to government tenders.
  • Bidders must demonstrate compliance with 'Make in India' policies to support local production and procurement.

Evaluation Process

The bids will be evaluated based on a technical and financial assessment involving:

  • Verification of documents to confirm compliance with eligibility criteria.
  • Technical evaluation that examines quality standards and specifications of the proposed products.
  • Financial evaluation based on competitive pricing coupled with the quality of goods offered.

Delivery Locations

Delivery should be made available to designated military healthcare facilities as directed by the Department of Defence.

Contact Information

For additional details, bidders may contact the Department of Defence through official channels provided on the tender submission website. However, specific contact information is not listed in the tender documentation.

This procurement process is a crucial step in ensuring that the Department of Defence receives the necessary medical supplies for the healthcare management of its personnel, tending to their needs with efficiency and quality-driven solutions.


General Information

Item Category
Human Insulin Analogue Glargine Recombinant DNA origin 450 IU or 1 point 5 ml PFS Disposable Pen with 5 needles per pen , Insulin Glulisine Injection Cartridge 100 IU or ml of 03 ml , Inj Insulin Aspart 100 U or ml of 3 Ml Pen , Insulin Aspart 50 percent plus Protamin Crystallised Aspart 50 percent 100 Iu or Ml of 3Ml Pen , Insulin Humalog Lispro Inj Recombinan Dna Origin 100 IU or ml of 3 ml cartridge , Soluble Insulin Injection 40 IU or ml of Human Actrapid Vial of 10 ml
Ministry Name
Department Name
State
City

Financial Information

EMD Amount
₹2,520.00
OEM Average Turnover
₹9.00 Lakh (s)
Minimum Turnover
₹9.00 Lakh (s)
Bid Offer Validity
180 (Days)
Past Performance
50 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
RA Qualification Rule
H1-Highest Priced Bid Elimination
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

4 Documents
GeM-Bidding-7747412.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover
  • Additional Doc 1 (Requested in ATC)
  • Additional Doc 2 (Requested in ATC)
  • Additional Doc 3 (Requested in ATC)
  • Additional Doc 4 (Requested in ATC) *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Succinylchloline Chloride 50 mg per ml, 2 ml Inj,Cap Tacrolimus 0.25 mg,Flavoxate 200mg Tab,Erythro

GEM
Goods
Qty:47.3K
4 Files
Indian Navy
UTTARA KANNADA, KARNATAKA
Boq › Boql
Succinylchloline Chloride 50 mg per ml, 2 ml Inj , Cap Tacrolimus 0.25 mg , Flavoxate 200mg Tab , Erythropoeitin Human Recombinant 4000 IU , Papaverine Hydrochloride 50 mg, 2 ml Inj , Sevelamer Carbonate Sachet 800mg , Human Insulin Analogue Glargine Inj, 100 IU per ml, Recombinant DNA origin, 300 IU disposable pen with 5 needles per pen , Gentamicin sulphate 0.3 percent, gentamicin base with Hydrocortisone acetate IP 1 percent weight in volume eye and ear drops bott of 5 ml , Brimonidine Tartrate 0.2 percent, Eye drops , Clobazam 5 mg Tab , Lorazepam 2 mg per ml, 2 ml Inj , Gabapentin 300 mg Cap or Tab , Sodium Valproate 100 mg per ml Inj , Lamotrigine 25 mg Tab , Sumatriptan 50 mg Tab , Topiramate 25 mg Tab , Nimodipine 30 mg Tab , Canagliflozin 100mg tab , Carbimazole 20 mg Tab , Tab Tenofovir 300mg , Tab Entacavir 0.5mg , Omeprazole 20 mg Cap , Pantoprazole 40mg Inj , Ranitidine HCl 50 mg, 2 ml Inj , Metoclopramide syrup 5mg per 5ml bott of 30ml , Hydrocortisone Enema 10 percentage , Dicyclomine HCl 20 mg Inj , Tab or Cap Dicyclomine 10mg , Bisacodyl 5 mg Tab , Sodium phosphate solution 45 ml, each Pack of 2 bottle , Tab Dapagliflozin 10mg , Iron Syp Pediatric Each 5 ml Containing elemental iron of 50 mg as iron polymaltose complex in 200 m... , Baclofen XL 30 mg Tab , Clozapine 50 mg Tab , Ranolazine 500 mg Tab , Oral Contraceptive Pills-Mala D Ethinyl Estradiol 0.03 mg, Norgestrel 0.30 mg Tab
April 25, 2025
May 16, 2025 at 10:00 AM
View Details

Ibuprofen Syrup 100 mg per 5ml Bott of 50 ml,Syp Fexofenadine 30 mg per ml in 60 ml bottle,Methyl P

₹9,900.00
GEM
Goods
Qty:2L
4 Files
Indian Army
PUNE, MAHARASHTRA
Boq › Boql
Ibuprofen Syrup 100 mg per 5ml Bott of 50 ml , Syp Fexofenadine 30 mg per ml in 60 ml bottle , Methyl Prednisolone 16mg Tab , Carbamazepine 200 mg Tab , Clobazam 5mg Tab , Clonazepam 2 mg Tab , Budesunide 1mg Respules , Mycophenolate 250mg Tab , Ivermectin Tab 6mg , Rifampicin 150mg Cap , Clotrimazole mouth paint , Fluconazole 50 mg cap , Primaquine 7.5mg base Tab , Cyclosporine A micro emulsion 100 mg Cap , Cyclosporine A micro emulsion 100 mg per ml bottle of 50 ml , Thalidomide 100mg Tab , Trihexyphenidyl HCl 2 mg Tab , Simvastatin 20mg Tab , Enalapril Maleate 2.5 mg Tab , Labetalol HCl 100 mg Tab , Triamcinolone Acetonide 0.1 percent for oral use tube of 5 gm , Adapalene 0.1percent Tube of 15 gm , 0.05percent Halobetasol Propionate and 3percent Salicylic acid ointment , Benzoyl Peroxide 2.5percent Tube of 20 gm , Clindamycin phosphate 1percent topical gel Tube of 10 gm , Hydroquinone 2percent Tube of 50 gm , Isotretinoin 20 mg Cap , Terbinafine 1percent cream, tube of 10 gm , Tretinoin 0.05percent, tube of 20 gm , Lignocaine 2.5percent and Prilocaine 2.5percent Tube of 30gm , Acitretin 25 mg Cap , Sodium Hypochlorite 5percent , 1percent wv available iodine in non oxynoi iodine surfactant base 500 ml bott , Chlorhexidine gluconate 2percent in 70percent isopropyl alcohol, 500 ml bott , Povidone Iodin 10percent solution 500 ML , Hydrogen peroxide solution with stabilizer IP 20 volume 500 ml Bott , Chlorhexidine Gluconate BP 7.5percent vv and Cetrimide BP 15percent wv 500 ml , Povidone Iodine solution 5percent bottle of 100 ml , Hydrocortisone 20mg Tab , Hydroxyprogesterone Caproate 500 mg per 2 ml Amp of 2 ml Inj , Clotrimazole Vaginal Pessary 100mg , Povidone Iodine 200 mgm Pessary , Human Insulin Analogue Rapid acting Inj 100 IU per ml 300 IU Disposable Pen , Tab Vildagliptin 50mg , CALCIUM ACETATE 500 MG TAB , Tacrolimus 0.5mg Tab , Acyclovir ophth Ointment 3percent WW in 5 Gm Tube , Lignocaine Hyrochloride 4percent topical solution bott of 30 ml , Syp Diphenhydramine 10 to 15 per 5 ml 100 ml , Cinnarizine 25 mg Tab , Norflox Syp 100mg per 5ml bott of 30 ml , Ondansetron Syp 2 mg per 5ml in bott of 30 ml , Iron drops to Fe Fumarate 10-12.5 mg elemental Fe per ml 15 ml , Fluvoxamine 50 mg Cap , Risperidone 2mg Tab , Beclomethasone 150 mcg Levosalbutamol 100mcg per MDI 200 dose units , Ipratropium Bromide Respirator Soln 500mcg per 2ml respule , Levo-Salbutamol sulphate 2.5ml containg 1.25mg respule , Bromhexine syp 5 ml containing 4 mg of Bromhexine Hcl bottle of 100ml , Hemostatic Sponge Gelatin 80 Mm Long and 50Mm Broad 10 Mm Thick , Sildenafil citrate 50 mg Tab , Tolterodine Tartrate 2 mg Tab , Iron syp with multi vitamins elemental iron and folic acid vit B12 min 100ml , Salmeterol and Fluticasone multidose dry powder inhaler of 60 dose Seretide , Capsacain Gel Tube of 20 gm per Intagesic Hot , Sulphamethoxazole 200 mg And Trimethoprim 40mg 50ml Suspn , Disposable gown , Hand Gloves size 7 pair of
April 22, 2025
May 13, 2025 at 2:00 PM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity capable of supplying medicinal products. Specifically, bidders should demonstrate experience in providing pharmaceuticals, especially insulin products, along with compliance with health regulations.

Bidders must submit various certificates including quality assurance certifications from health authorities, as well as proof of registration as a pharmaceutical supplier. It’s vital to ensure that all submitted documents adhere to stipulations set by the issuing authority.

The registration process involves signing up on the official bidding platform where the tender is listed. Bidders must complete all necessary fields, and provide required documents to gain access to participate in the procurement process.

Accepted document formats typically include PDF and Word documents. It is advisable to follow any specific format guidelines stated on the bidding platform to ensure compliance.

Payment terms generally follow the agreed contract stipulating timelines based on deliverables. The evaluation process focuses on both price competitiveness and compliance with quality and technical specifications, thus ensuring the best value for the Department of Defence.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders